Sabra Health Care REIT (NASDAQ:SBRA) issued its quarterly earnings data on Sunday. The real estate investment trust reported $0.18 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.43 by ($0.25), MarketWatch Earnings reports. Sabra Health Care REIT had a net margin of 23.42% and a return on equity of 4.15%.
NASDAQ:SBRA opened at $18.44 on Tuesday. The stock has a 50-day simple moving average of $17.42 and a 200 day simple moving average of $16.08. Sabra Health Care REIT has a 52-week low of $5.55 and a 52-week high of $22.47. The company has a market cap of $3.82 billion, a PE ratio of 26.73 and a beta of 1.49. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.01 and a current ratio of 1.01.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 26th. Stockholders of record on Friday, February 12th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 6.51%. The ex-dividend date is Thursday, February 11th. Sabra Health Care REIT’s dividend payout ratio is 64.52%.
Several research firms have recently commented on SBRA. Smith Barney Citigroup upped their price target on shares of Sabra Health Care REIT from $14.00 to $17.00 in a research report on Tuesday, December 15th. Jefferies Financial Group upgraded Sabra Health Care REIT from a “hold” rating to a “buy” rating and boosted their price target for the stock from $17.00 to $20.00 in a research report on Wednesday, January 13th. TheStreet raised Sabra Health Care REIT from a “c+” rating to a “b-” rating in a research note on Tuesday, November 24th. JMP Securities raised Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $24.00 target price on the stock in a report on Thursday, December 3rd. Finally, Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell boosted their target price on shares of Sabra Health Care REIT from $14.00 to $17.00 in a report on Tuesday, December 15th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $17.08.
About Sabra Health Care REIT
As of September 30, 2020, Sabra's investment portfolio included 425 real estate properties held for investment (consisting of (i) 287 Skilled Nursing/Transitional Care facilities, (ii) 64 Senior Housing communities (ÂSenior Housing – LeasedÂ), (iii) 47 Senior Housing communities operated by third-party property managers pursuant to property management agreements (ÂSenior Housing – ManagedÂ) and (iv) 27 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a direct financing lease, 19 investments in loans receivable (consisting of (i) one mortgage loan, (ii) one construction loan and (iii) 17 other loans), six preferred equity investments and one investment in an unconsolidated joint venture that owns 158 Senior Housing – Managed communities.
Further Reading: Swap
Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.